Answer
Women of childbearing potential receiving marstacimab (Hympavzi) should use effective contraception throughout treatment and for at least one month after stopping treatment.
Sources for this answer
- Hympavzi 150 mg solution for injection in pre-filled penPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked